248 related articles for article (PubMed ID: 29383453)
21. Effect of co-medications and potential risk factors of high-dose methotrexate-mediated acute hepatotoxicity in patients with osteosarcoma.
Wang SF; Huang KW; Chou YC; Lee HC; Wu PK; Chen WM; Hung GY; Chang YL
Cancer Med; 2023 Jun; 12(11):12354-12364. PubMed ID: 37062070
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole.
Yukawa K; Nagamoto Y; Watanabe H; Funaki M; Iwahashi M; Yamana J; Sasaki R; Yamana S
J Clin Rheumatol; 2018 Oct; 24(7):355-360. PubMed ID: 29664819
[TBL] [Abstract][Full Text] [Related]
23. Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients.
Buijs BS; van den Berk GE; Boateng CP; Hoepelman AI; van Maarseveen EM; Arends JE
AIDS; 2015 Apr; 29(7):785-91. PubMed ID: 25985401
[TBL] [Abstract][Full Text] [Related]
24. Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study.
Mendel A; Behlouli H; de Moura CS; Vinet É; Curtis JR; Bernatsky S
Arthritis Res Ther; 2023 Jul; 25(1):133. PubMed ID: 37516897
[TBL] [Abstract][Full Text] [Related]
25. A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
Fox MT; Melia MT; Same RG; Conley AT; Tamma PD
Am J Med; 2017 Jul; 130(7):842-845. PubMed ID: 28216442
[TBL] [Abstract][Full Text] [Related]
26. [Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis--case report and review of literature].
Kitsuwa S; Matsunaga K; Kawai M; Tsuzi T; Kato K; Tani K; Okubo T
Ryumachi; 1996 Jun; 36(3):551-8. PubMed ID: 8779792
[TBL] [Abstract][Full Text] [Related]
27. Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.
Utsunomiya M; Dobashi H; Odani T; Saito K; Yokogawa N; Nagasaka K; Takenaka K; Soejima M; Sugihara T; Hagiyama H; Hirata S; Matsui K; Nonomura Y; Kondo M; Suzuki F; Tomita M; Kihara M; Yokoyama W; Hirano F; Yamazaki H; Sakai R; Nanki T; Koike R; Kohsaka H; Miyasaka N; Harigai M
Arthritis Res Ther; 2017 Jan; 19(1):7. PubMed ID: 28100282
[TBL] [Abstract][Full Text] [Related]
28. A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases.
Takenaka K; Komiya Y; Ota M; Yamazaki H; Nagasaka K
Mod Rheumatol; 2013 Jul; 23(4):752-8. PubMed ID: 22907597
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.
Gomolin IH; Siami PF; Reuning-Scherer J; Haverstock DC; Heyd A;
J Am Geriatr Soc; 2001 Dec; 49(12):1606-13. PubMed ID: 11843992
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study.
Creemers-Schild D; Kroon FP; Kuijper EJ; de Boer MG
Infection; 2016 Jun; 44(3):291-9. PubMed ID: 26471512
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy.
Li C; Lu F; Lei T; Yu H; Chen X; Peng S; Han S; Yang H
BMC Cancer; 2020 Aug; 20(1):742. PubMed ID: 32770971
[TBL] [Abstract][Full Text] [Related]
32. Does Trimethoprim-Sulfamethoxazole prophylaxis induce myelosuppression in primary immune deficiency disease patients; A retrospective, 3 groups comparative study.
Elajez R; Nisar S; Adeli M
Asian Pac J Allergy Immunol; 2023 Dec; 41(4):353-360. PubMed ID: 33068365
[TBL] [Abstract][Full Text] [Related]
33. Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure.
Tsapepas D; Chiles M; Babayev R; Rao MK; Jaitly M; Salerno D; Mohan S
Am J Med; 2016 Dec; 129(12):1322-1328. PubMed ID: 27542610
[TBL] [Abstract][Full Text] [Related]
34. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
35. The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group.
Bozzette SA; Forthal D; Sattler FR; Kemper C; Richman DD; Tilles JG; Leedom J; McCutchan JA
Am J Med; 1995 Feb; 98(2):177-82. PubMed ID: 7847434
[TBL] [Abstract][Full Text] [Related]
36. Effect of standard-dose trimethoprim/sulfamethoxazole on the serum potassium concentration in elderly men.
Witt JM; Koo JM; Danielson BD
Ann Pharmacother; 1996 Apr; 30(4):347-50. PubMed ID: 8729886
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.
Mengelers MJ; Van Gogh ER; Kuiper HA; Pijpers A; Verheijden JH; Van Miert AS
J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537
[TBL] [Abstract][Full Text] [Related]
38. Effect of Prophylactic Dose of Trimethoprim-Sulfamethoxazole on Serum Creatinine in Japanese Patients With Connective Tissue Diseases.
Kawato R; Rokutanda R; Okada M; Matsushita M; Yamaji K; Tamura N
Clin Med Insights Arthritis Musculoskelet Disord; 2022; 15():11795441221085141. PubMed ID: 35342315
[TBL] [Abstract][Full Text] [Related]
39. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
